Tandem Diabetes Care TNDM Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 54.9%+2.7pp | 53.8%+1.7pp | 53.2%+3.4pp | 52.5%+3.5pp | 52.2%+2.9pp | |
| Operating margin | -8.2%+10.0pp | -18.5%-7.9pp | -19.5%-3.8pp | -19.9%-2.4pp | -18.1%+1.0pp | |
| Net margin | -9.2%+9.5pp | -20.2%-10.0pp | -20.2%-5.4pp | -20.5%-3.4pp | -18.7%-0.3pp | |
| Returns | ||||||
| Return on equity | -65.7%+26.6pp | -97.9%-64.6pp | -109.7%-63.8pp | -111.9%-63.4pp | -92.3%-43.7pp | |
| Return on invested capital | -13.1%+26.2pp | -30.8%-16.4pp | -32.8%-7.9pp | -32.6%-5.8pp | -39.2%+5.2pp | |
| Efficiency | ||||||
| Asset turnover | 1×-0.1× | 1.1×+0.1× | 1.1×+0.2× | 1.1×+0.3× | 1.1×+0.2× | |
| Liquidity | ||||||
| Current ratio | 3.6×+1.3× | 2.5×-0.4× | 2.4×-0.5× | 2.4×-0.6× | 2.3×-1.5× | |
| Leverage | ||||||
| Debt-to-equity | 5.5×+2.4× | 2.9×+0.9× | 3.4×+1.2× | 3.4×+1.2× | 3.2×+2.6× | |
| Per Share | ||||||
| Book value per share | $1.94-17.2% | $2.28-42.6% | $1.97-45.8% | $1.99-44.8% | $2.34-37.1% | |
| Valuation | ||||||
| Market capitalization | $1.03B-23.6% | $1.49B-37.0% | $820.29M-70.5% | $1.34B-48.3% | $1.27B-45.2% | |
| Price / sales | 1×-0.4× | 1.5×-1.0× | 0.8×-2.4× | 1.3×-1.9× | 1.3×-1.7× | |
| Price / book | 7.8×-0.9× | 9.6×+0.6× | 6.2×-5.5× | 10.1×-1.0× | 8.2×-1.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Tandem Diabetes Care's profit margins?
- Tandem Diabetes Care (TNDM) runs a 54.9% gross margin and a -8.2% operating margin, with a -9.2% net margin.
- Where do Tandem Diabetes Care's ratios come from?
- Every ratio is computed from Tandem Diabetes Care's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
